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Furthermore, high quality teaching and learning
do not happen by accident: a curriculum is initially no
more than a document. Medical schools must engage
with the foundation programme, helping to develop
expertise in medical education and ensuring that the
years spent as junior hospital doctors are part of a
smooth transition for graduates. There will have to be
rapid expansion in the number of medical graduates
who have been taught to teach—those with formal
training in methods of teaching and learning.
Postgraduate training in medical education may have
to become a formal requirement for at least some
clinicians in each teaching facility, and medical educa-
tion may develop into a formal postgraduate medical
specialty. Lastly, the current difficult pathways for
medical practitioners to gain formal educational quali-
fications may need to be simplified, with more flexible
professional doctorates or membership courses.
The success of the foundation programme, then,
will require genuine academic development and
support throughout the entire healthcare system,
rather than in a relatively small number of elite teach-
ing facilities.
Richard Hays professor of medical education
School of Medicine, James Cook University, Queensland 4811,
Australia
(richard.hays@jcu.edu.au)
Competing interests: None declared.
1 National Health Service. Modernising medical careers: foundation
programmes. www.mmc.nhs.uk/pages/foundation (accessed 25 Aug 2005).
2 Gallen D, Peile E. A firm foundation for senior house officers. BMJ 2004;
328:1390-1.
3 General Medical Council. Good medical practice. 3rd ed. London: GMC,
2001. www.gmc-uk.org/standards/good.htm (accessed 25 Aug 2005).
4 National Health Service. The rough guide to the foundation programme.
London: Stationery Office, 2005. www.mmc.nhs.uk/download_files/
The-Rough-Guide-to-the-Foundation-Programme.pdf (accessed 25 Aug
2005).
5 MacDonald J. A survey of staff attitudes to increasing medical
undergraduate education in a district general hospital.Med Educ 2005;39:
668-74.
6 BBC News Online. Junior doctors’ training revamped. http://news.bbc.
co.uk/1/hi/health/4131420.stm (accessed 25 Aug 2005).
7 Junior doctors face unemployment. http://news.bbc.co.uk/1/hi/health/
4720905.stm (accessed 25 Aug 2005).
8 Evans J, Lambert T, Goldacre M. GP recruitment and retention: a qualita-
tive analysis of doctors’ comments about training for and working in gen-
eral practice. Occas Pap R Coll Gen Pract 2003;83(iii-vi):1-33.
9 Schwartz MD, BascoWT,Grey MR , Elmore JG, Rubenstein A. Rekindling
student interest in generalist careers. Ann Intern Med 205;142:715-24.
Self monitoring of high blood pressure
Doing it in the practice’s waiting room may be better than doing it at home
Lowering raised blood pressure reduces patients’risk of developing cardiovascular disease.1 2 Butthe control of hypertension is often suboptimal,
and this is borne out by the poorer effectiveness of
treatment in observational studies than in randomised
clinical trials.3 A recent systematic review by Fahey and
colleagues emphasised that effective care for people
with hypertension requires rigorous management with
regular review and willingness to intensify drug
treatment.4
The outcome of regular care depends on patients
as much as, or more than, it does on practitioners. Evi-
dence on managing chronic diseases such as diabetes
mellitus and asthma emphasises the value of patients’
participation, and the same is probably true for self
monitoring of blood pressure. Measuring blood
pressure is straightforward and has become even more
so with the development of validated electronic meas-
uring devices, which are now available to the public.5
Self monitoring satisfies the public’s demand for more
self control and knowledge about health and disease.
In addition, it may affect workload in primary care.
A randomised controlled trial by McManus and
colleagues in this issue (p 493) reports on self
monitoring of blood pressure in the patient’s general
practice rather than at home.6 Practice based self
monitoring of blood pressure is an original concept
and is worth testing. The self measured and
professionally measured blood pressure values were
comparable, suggesting that hypertension guidelines,
which will be based for the foreseeable future on pro-
fessional measurement data, are applicable to self
monitoring. In this study self monitoring resulted in a
cost effective reduction in blood pressure, with no
increase in patients’ anxiety.
This new study provides valuable empirical data in
line with earlier studies showing that home monitoring
is more effective than usual care in controlling blood
pressure and achieving targets.7 This effect is probably
explained by the absence of a white coat effect and
better adherence to treatment through self control.
Despite these promising findings, some important
questions remain unresolved.
Even though small gains in blood pressure
reduction provided by self monitoring are clinically
relevant, it is crucial to know whether they can be sus-
tained over time, given the chronic nature of hyperten-
sion. If adherence to home monitoring declines over
time it could lead to even poorer control of blood
pressure through diminished contact between patients
and doctors.8 Yet the average follow-up in all but a few
studies of self monitoring has been less than a year.7
A weakness in the study byMcManus and colleagues
was the absence of cluster randomisation. As a
consequence, general practitioners may have optimised
their measurement during usual care, diminishing the
effect size. Furthermore, systematic reviews show that
most studies have been marred by methodological
problems and have included only a small part of the
hypertensive population in general practice.4 7 Self
selection by enthusiastic participants in these studies
may partly explain effectiveness, and this makes it
difficult to recommend self measurement to all patients.9
Self monitoring of blood pressure should be part of
a plan that includes patients more fully in decisions over
treatment; includes regular checks of patients’ blood
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pressure measurement technique; and provides some
form of regular professional supervision. The hyperten-
sive population in general practice is heterogeneous—
for example, in terms of age, comorbidity, and individual
preferences.10 That many patients declined the offer to
join the self measurement group in the study by
McManus and colleagues hampered recognitions of this
heterogeneity. A practical solution could be to offer self
monitoring only to those most likely to practise it, prob-
ably minimising the risk of anxiety and other adverse
effects among patients. Testing patients’ motivation and
allocating a treatment strategy accordingly, along the
lines of the stages of change model used in risk factor
management, could facilitate selection.11
Given that the current value of self monitoring of
blood pressure remains uncertain, we recommend
carefully designed experiments within the broader
context suggested in the Cochrane review by Fahey
and colleagues.4 Consultation at the practice at least
once a year seems necessary to check whether the con-
ditions for successful self measurement of blood pres-
sure are still in place. But practice based self
monitoring, as introduced by McManus and col-
leagues, offers a greater safety net. It allows active par-
ticipation by patients without losing professional
supervision, which may prove to be a considerable
advantage over self monitoring at home.
J Carel Bakx senior researcher
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Coronary heart disease in women
Is underdiagnosed, undertreated, and under-researched
Coronary heart disease remains the leadingcause of death in men and women worldwide,and cardiovascular deaths exceed the number
of deaths from all cancers combined. In the United
Kingdom, coronary heart disease causes almost
114 000 deaths a year, and one in six occurs in
women.1 In the UK and Europe, one woman dies every
six minutes of heart disease and in the United States,
one every minute. Moreover, in Europe, cardiovascular
disease kills a higher percentage of women (55%) than
men (43%).2 Yet coronary heart disease is still
considered a disease of men.
Many women are unaware that coronary heart
disease is their main killer; their biggest fear is breast
cancer. Even more worrying, however, is the apparent
lack of awareness of cardiovascular disease in women
among healthcare professionals. At the time of presen-
tation with heart disease, women tend to be 10 years
older than men, and at the time of their first
myocardial infarction they are usually 20 years older.3 4
As coronary heart disease is a disease of the older
woman, many women believe that they can postpone
attempts to reduce their risk.
Risk factors for heart disease differ between the
sexes. For example, women with diabetes have 2.6
times the risk of dying from coronary heart disease
than women without diabetes compared with a 1.8-fold
risk among men with diabetes.3 Similarly hypertension
is associated with a twofold to threefold increased risk
of coronary events in women.3 Low concentrations of
high density lipoprotein seem to be a better predictor
of coronary risk in women than high concentrations of
low density lipoprotein.3 Furthermore, high levels of
triglyceride are associated with greater risk among
women than men.3
Women and men with heart disease tend to differ
in their presenting symptoms, their access to investiga-
tions and treatment, and their overall prognosis.
Women may have more atypical symptoms than
men—such as back pain, burning in the chest, abdomi-
nal discomfort, nausea, or fatigue—which makes the
diagnosis more difficult. Women are less likely to seek
medical help and tend to present late in the process of
their disease. They are also less likely to have appropri-
ate investigations, such as coronary angiography and,
together with late presentation to hospital, this can
delay the start of effective treatment.
There are particularly clear sex differences in
patients undergoing coronary revascularisation: mor-
tality in women is notably higher.5–7 At the time of
presentation with coronary artery disease, women are
more likely to have comorbid factors such as diabetes
mellitus, hypertension, hypercholesterolaemia, periph-
eral vascular disease, and heart failure.8 In addition,
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